Polyclonal antibody composition for treating allergy

Polyclonal antibody composition for treating allergy

A pharmaceutical composition for treating allergy is described. The composition comprises as an active ingredient a recombinant polyclonal antibody or a mixture of different monoclonal antibodies capable of reacting with or binding to an allergen together with one or more pharmaceutically acceptable...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Haurum, John S, Drejer, Kirsten, Morch, Ulrik Gregers Winther
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Haurum, John S
Drejer, Kirsten
Morch, Ulrik Gregers Winther
description A pharmaceutical composition for treating allergy is described. The composition comprises as an active ingredient a recombinant polyclonal antibody or a mixture of different monoclonal antibodies capable of reacting with or binding to an allergen together with one or more pharmaceutically acceptable excipients. The composition may be used topically as a solution, dispersion, powder, or in the form of microspheres. The polyclonal antibody is preferably a recombinant polyclonal antibody produced by phage display technology. The pairing of specific immunoglobulin variable region light chain and heavy chain maintained from the original polyclonal immune response or selected by panning using the allergen in question is preferably maintained by bulk transfer of the pairs into an expression vector.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_06849259</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>06849259</sourcerecordid><originalsourceid>FETCH-uspatents_grants_068492593</originalsourceid><addsrcrecordid>eNrjZDAJyM-pTM7Jz0vMUUjMK8lMyk-pVEjOzy3IL84syczPU0jLL1IoKUpNLMnMS1dIzMlJLUqv5GFgTUvMKU7lhdLcDApuriHOHrqlxQWJJal5JcXx6UWJIMrAzMLE0sjU0pgIJQBYiS5_</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Polyclonal antibody composition for treating allergy</title><source>USPTO Issued Patents</source><creator>Haurum, John S ; Drejer, Kirsten ; Morch, Ulrik Gregers Winther</creator><creatorcontrib>Haurum, John S ; Drejer, Kirsten ; Morch, Ulrik Gregers Winther ; Symphogen A/S</creatorcontrib><description>A pharmaceutical composition for treating allergy is described. The composition comprises as an active ingredient a recombinant polyclonal antibody or a mixture of different monoclonal antibodies capable of reacting with or binding to an allergen together with one or more pharmaceutically acceptable excipients. The composition may be used topically as a solution, dispersion, powder, or in the form of microspheres. The polyclonal antibody is preferably a recombinant polyclonal antibody produced by phage display technology. The pairing of specific immunoglobulin variable region light chain and heavy chain maintained from the original polyclonal immune response or selected by panning using the allergen in question is preferably maintained by bulk transfer of the pairs into an expression vector.</description><language>eng</language><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6849259$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,798,881,64012</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6849259$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Haurum, John S</creatorcontrib><creatorcontrib>Drejer, Kirsten</creatorcontrib><creatorcontrib>Morch, Ulrik Gregers Winther</creatorcontrib><creatorcontrib>Symphogen A/S</creatorcontrib><title>Polyclonal antibody composition for treating allergy</title><description>A pharmaceutical composition for treating allergy is described. The composition comprises as an active ingredient a recombinant polyclonal antibody or a mixture of different monoclonal antibodies capable of reacting with or binding to an allergen together with one or more pharmaceutically acceptable excipients. The composition may be used topically as a solution, dispersion, powder, or in the form of microspheres. The polyclonal antibody is preferably a recombinant polyclonal antibody produced by phage display technology. The pairing of specific immunoglobulin variable region light chain and heavy chain maintained from the original polyclonal immune response or selected by panning using the allergen in question is preferably maintained by bulk transfer of the pairs into an expression vector.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZDAJyM-pTM7Jz0vMUUjMK8lMyk-pVEjOzy3IL84syczPU0jLL1IoKUpNLMnMS1dIzMlJLUqv5GFgTUvMKU7lhdLcDApuriHOHrqlxQWJJal5JcXx6UWJIMrAzMLE0sjU0pgIJQBYiS5_</recordid><startdate>20050201</startdate><enddate>20050201</enddate><creator>Haurum, John S</creator><creator>Drejer, Kirsten</creator><creator>Morch, Ulrik Gregers Winther</creator><scope>EFH</scope></search><sort><creationdate>20050201</creationdate><title>Polyclonal antibody composition for treating allergy</title><author>Haurum, John S ; Drejer, Kirsten ; Morch, Ulrik Gregers Winther</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_068492593</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2005</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Haurum, John S</creatorcontrib><creatorcontrib>Drejer, Kirsten</creatorcontrib><creatorcontrib>Morch, Ulrik Gregers Winther</creatorcontrib><creatorcontrib>Symphogen A/S</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Haurum, John S</au><au>Drejer, Kirsten</au><au>Morch, Ulrik Gregers Winther</au><aucorp>Symphogen A/S</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Polyclonal antibody composition for treating allergy</title><date>2005-02-01</date><risdate>2005</risdate><abstract>A pharmaceutical composition for treating allergy is described. The composition comprises as an active ingredient a recombinant polyclonal antibody or a mixture of different monoclonal antibodies capable of reacting with or binding to an allergen together with one or more pharmaceutically acceptable excipients. The composition may be used topically as a solution, dispersion, powder, or in the form of microspheres. The polyclonal antibody is preferably a recombinant polyclonal antibody produced by phage display technology. The pairing of specific immunoglobulin variable region light chain and heavy chain maintained from the original polyclonal immune response or selected by panning using the allergen in question is preferably maintained by bulk transfer of the pairs into an expression vector.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_06849259
source USPTO Issued Patents
title Polyclonal antibody composition for treating allergy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T14%3A38%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Haurum,%20John%20S&rft.aucorp=Symphogen%20A/S&rft.date=2005-02-01&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E06849259%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true